Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2012
03/06/2012CA2290944C Pgc-1, a novel brown fat ppar.gamma. coactivator
03/06/2012CA2253924C Vasoactive amine binding molecules
03/06/2012CA2202408C Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
03/03/2012CA2714364A1 Auxin receptors
03/01/2012WO2012027580A1 Filamentous fungi having an altered viscosity phenotype
03/01/2012WO2012027494A1 Bispecific targeting reagents
03/01/2012WO2012027376A2 Method for expansion of stem cells and the use of such cells
03/01/2012WO2012027365A2 Targeted multi-epitope dosage forms for induction of an immune response to antigens
03/01/2012WO2012026596A1 Method for increasing thermal hysteresis activity, method for reducing thermal inactivation of thermal hysteresis activity, and composition for increasing thermal hysteresis activity
03/01/2012WO2012025753A1 Enterococcus faecium strain suitable for prevention or retardation of the growth of listeria
03/01/2012WO2012025651A1 Biomaterial comprising osteostatin for osseous regeneration and tissue engineering
03/01/2012WO2012025629A1 Whole-cell biotransformation of fatty acids to obtain fatty aldehydes shortened by one carbon atom
03/01/2012WO2012025616A1 Means and methods for the detection of a predisposition of a female subject to recurrent pregnancy loss (rpl), preeclampsia (pe) and/or fetal growth restriction (fgr)
03/01/2012WO2012025582A2 Method for producing highly concentrated solutions of self-assembling proteins
03/01/2012WO2012004401A3 Preformed defense in plants
03/01/2012WO2012003398A8 Protein precursors as prodrugs
03/01/2012WO2011154349A3 Fgf21 analogues and derivatives
03/01/2012WO2011143400A3 Method and composition for inducing human pluripotent stem cells
03/01/2012WO2011143299A3 Differentiation of human embryonic stem cells
03/01/2012WO2011139973A3 Methods of inhibiting fibrosis using anti-pai-1 antibodies
03/01/2012WO2011132089A3 Methods for tissue decellularization
03/01/2012WO2011125015A3 Protease-activatable pore-forming polypeptides
03/01/2012WO2011119628A3 Compositions and methods for self-adjuvanting vaccines against microbes and tumors
03/01/2012WO2011060534A8 Trim5alpha mutants and uses thereof
03/01/2012WO2003053332A3 Composition and method for treating viral infection
03/01/2012WO2003002067A3 Inhibition of tumor growth and metastasis by n5 gene
03/01/2012US20120054912 Vacuole Targeting Peptides and Methods of Use
03/01/2012US20120054910 Antipathogenic Proteins and Methods of Use
03/01/2012US20120054906 Method for Preparation and Purification of Recombinant Proteins
03/01/2012US20120054904 Soybean Cultivar 2252921658
03/01/2012US20120054903 Soybean Cultivar 2366062471
03/01/2012US20120054902 Soybean Cultivar 2393321658
03/01/2012US20120054901 Soybean Cultivar 4310350112
03/01/2012US20120054900 Soybean Cultivar 2585850112
03/01/2012US20120054899 Soybean Cultivar 9531302
03/01/2012US20120054898 Soybean Cultivar 9728361
03/01/2012US20120054897 Soybean Cultivar 9445098
03/01/2012US20120054879 HCV Coreceptor and Methods of Use Thereof
03/01/2012US20120053509 Vaccines for human papilloma virus and methods for using the same
03/01/2012US20120053322 Passive methods for anti-microbial biological meshes
03/01/2012US20120053321 Zcytor19 heterodimeric cytokine receptor polynucleotides, polypeptides, antibodies and methods
03/01/2012US20120053320 Microbial nanowires and methods of making and using same
03/01/2012US20120053319 Microbial nanowires
03/01/2012US20120053318 Method of radiolabeling
03/01/2012US20120053234 Hepcidin Binding Nucleic Acids
03/01/2012US20120053232 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN TUMOR SUPPRESSING SUBTRANSFERABLE CANDIDATE 4 (TSSC4)
03/01/2012US20120053125 Phosphatase inhibitor protein-1 as a regulator of cardiac function
03/01/2012US20120053124 Binder for c-reactive protein
03/01/2012US20120053123 Natriuretic polypeptides having mutations within their disulfide rings
03/01/2012US20120053115 Lantibiotic Carboxyamide Derivatives With Enhanced Antibacterial Activity
03/01/2012US20120053080 Protein markers identification for gastric cancer diagnosis
03/01/2012US20120053072 Methods and compositions for diagnosis and prognosis of renal injury and renal failure
03/01/2012US20120052574 Novel reagents for transfection of eukaryotic cells
03/01/2012US20120052552 Method of separating components of technical eggs, edible eggs, yolk and whites and products therefrom
03/01/2012US20120052550 Temperature-responsive polymer particles in protein separation applications
03/01/2012US20120052545 Lipolytic Enzyme LIP2
03/01/2012US20120052513 Gold sub-nanoclusters and uses thereof
03/01/2012US20120052484 Methods of diagnosing cervical cancer
03/01/2012US20120052136 Novel heamoglobin and uses thereof
03/01/2012US20120052110 Methods and compositions for promoting wound healing
03/01/2012US20120052104 Polypeptides and Antibacterial or Antiseptic Use of Same
03/01/2012US20120052092 Vaccine compositions comprising a mutated factor h binding protein
03/01/2012US20120052091 Potomac horse fever isolates
03/01/2012US20120052087 Siderophore Conjugate Immunogenic Compositions and Vaccines
03/01/2012US20120052086 Vaccine composition for prophylaxis and/or therapy of alzheimer's disease
03/01/2012US20120052084 Staphylococcus aureus proteins and nucleic acids
03/01/2012US20120052071 Tumor markers and methods of use thereof
03/01/2012US20120052069 Fgf21 mutants and uses thereof
03/01/2012US20120052065 Methods of treatment using ctla4 mutant molecules
03/01/2012US20120052048 Antibacterial phage, phage peptides and methods of use thereof
03/01/2012US20120052043 Chemokine-Chaperone Fusion Proteins
03/01/2012US20120052009 Imaging probes, methods of making imaging probes, and methods of imaging
03/01/2012CA2809342A1 Means and methods for the detection of a predisposition of a female subject to recurrent pregnancy loss (rpl), preeclampsia (pe) and/or fetal growth restriction (fgr)
03/01/2012CA2809029A1 Targeted multi-epitope dosage forms for induction of an immune response to antigens
03/01/2012CA2808777A1 Filamentous fungi having an altered viscosity phenotype
03/01/2012CA2807785A1 Novel defensin variants and methods of use
02/2012
02/29/2012EP2423685A1 Agent and method for diagnosis on the occurrence of Alzheimer's disease
02/29/2012EP2423684A2 Differential expression profiling analysis of cell culture phenotypes and the uses thereof
02/29/2012EP2423310A1 Cancer antigen helper peptide
02/29/2012EP2423233A2 In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasing in vivo half-life using same
02/29/2012EP2423224A1 Compositions and methods for modulating hemostasis
02/29/2012EP2423223A1 Novel exendin variant and conjugate thereof
02/29/2012EP2423222A1 Regulatory t cell epitopes, compositions and uses thereof
02/29/2012EP2423221A1 Regulatory t cell epitopes, compositions and uses thereof
02/29/2012EP2423220A1 Regulatory T cell epitopes, compositions and uses thereof
02/29/2012EP2423219A1 Regulatory t cell epitopes, compositions and uses thereof
02/29/2012EP2423217A1 Peptide and protein affinity tag from mistic protein
02/29/2012EP2423216A1 Replication competent hepatitis C virus and methods of use
02/29/2012EP2423176A1 Carboxylic acid compound
02/29/2012EP2422861A1 Method for identifying natural substances able to form a complex
02/29/2012EP2422808A2 Novel compounds and their effects on feeding behaviour
02/29/2012EP2422807A2 Hybrid polypeptides with selectable properties
02/29/2012EP2422806A2 Hybrid polypeptides with selectable properties
02/29/2012EP2422615A2 Dominant negative mutant krp protein protection of active cyclin-cdk complex inhibition by wild-type krp
02/29/2012EP2422201A1 Structure of the c-terminal region of the insulin receptor alpha -chain and of the insulin-like growth factor receptor alpha -chain
02/29/2012EP2422200A2 Methods and systems for identifying immunomodulatory substances
02/29/2012EP2421985A1 Yield enhancement in plants by modulation of a maize transcription coactivator p15 (pc4) protein
02/29/2012EP2421953A1 Method for chondrogenic differentiation of pluripotent or multipotent stem cells using wnt6
02/29/2012EP2421895A1 Recombinant human alpha1-antitrypsin
02/29/2012EP2421894A1 Method of preparing low-iron lactoferrin
1 ... 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 ... 2916